Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GFRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPA12B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C20orf194 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDRGK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on